Moderate

Gonococcal & chlamydial urethritis / cervicitis / PID syndromes (STI; non-gonococcal urethritis)

Discharge/dysuria; ceftriaxone + doxycycline; test-of-cure, partners, PID safety-net · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Common sexually transmitted causes of urethritis (men) and cervicitis/PID (women): Neisseria gonorrhoeae and Chlamydia trachomatis (plus Mycoplasma genitalium and non-specific causes in NGU). ED role: treat empirically per BASHH/CDC, screen for complications (PID, epididymo-orchitis, DGI), arrange partner notification and GUM follow-up including test-of-cure for gonorrhoea given rising ceftriaxone resistance.

Red flags

  • Lower abdominal pain + cervical excitation - PID (and exclude ectopic)
  • Fever, polyarthralgia, pustular rash - disseminated gonococcal infection
  • Testicular pain/swelling - epididymo-orchitis (vs torsion)
  • RUQ pain in PID - Fitz-Hugh-Curtis (perihepatitis)
  • Neonatal eye discharge / maternal infection - ophthalmia neonatorum

Assessment

Differential diagnosis

  • UTI
  • Non-gonococcal urethritis (M. genitalium, Ureaplasma, Trichomonas, adenovirus, HSV)
  • Epididymo-orchitis / prostatitis
  • Pelvic inflammatory disease / ectopic pregnancy / ovarian pathology
  • Reactive arthritis (post-chlamydial)
  • Disseminated gonococcal infection (arthritis-dermatitis)

Investigations

  • NAAT for N. gonorrhoeae + C. trachomatis (first-void urine in men; vulvovaginal/endocervical swab in women; plus rectal/pharyngeal swabs per exposure)
  • Gonococcal culture BEFORE treatment for antimicrobial susceptibility (critical given resistance)
  • Microscopy of urethral/cervical smear (Gram-negative intracellular diplococci; polymorphs)
  • Pregnancy test in women; consider M. genitalium NAAT with macrolide-resistance testing
  • Full STI screen: HIV, syphilis serology, hepatitis B/C per risk
  • If DGI: blood cultures, joint aspirate

Management

  • Treat empirically at presentation when STI likely (don't wait for results); take gonococcal culture first
  • Cover both organisms when gonorrhoea suspected/confirmed: ceftriaxone + doxycycline
  • Assess for complications: PID (lower abdo pain, cervical motion tenderness), epididymo-orchitis, DGI, Fitz-Hugh-Curtis
  • Advise abstinence until patient and partner(s) treated and 7 days after single-dose therapy / completion
  • Partner notification and contact tracing via GUM/health adviser
  • Arrange GUM referral + test-of-cure for gonorrhoea (~2 weeks); repeat NAAT and address M. genitalium if persistent
  • Safety-net for PID sequelae (infertility, ectopic, chronic pain)

Drugs & doses

Gonorrhoea (BASHH/CDC): ceftriaxone 1 g IM single dose (CDC uses 500 mg IM; 1 g if >=150 kg) - azithromycin co-treatment no longer routine
Gonorrhoea if ceftriaxone not possible / susceptibility known: cefixime 400 mg PO single dose + test-of-cure; or culture-guided ciprofloxacin 500 mg PO single dose only if proven susceptible
Chlamydia / NGU first-line: doxycycline 100 mg PO BD 7 days (21 days if LGV/rectal)
Chlamydia second-line / pregnancy: azithromycin 1 g PO then 500 mg OD days 2-3, OR amoxicillin 500 mg TDS 7 days (pregnancy)
Mycoplasma genitalium (macrolide-sensitive): doxycycline 100 mg BD 7 days then azithromycin 1 g then 500 mg OD 3 days; (resistant): doxycycline then moxifloxacin 400 mg OD 7-10 days [verify local]
PID (outpatient): ceftriaxone 1 g IM single dose + doxycycline 100 mg BD + metronidazole 400 mg BD for 14 days
Disseminated gonococcal infection: ceftriaxone 1-2 g IV/IM OD 7+ days
Pregnancy: avoid doxycycline and quinolones - use azithromycin/amoxicillin for chlamydia; ceftriaxone safe for gonorrhoea

Disposition

Most discharged with single-dose/short-course treatment, abstinence advice, partner notification and GUM/sexual-health follow-up + test-of-cure. Admit for severe PID, tubo-ovarian abscess, DGI, pregnancy with severe infection, or inability to tolerate oral therapy.

Complications & pitfalls

  • PID -> tubal infertility, ectopic pregnancy, chronic pelvic pain
  • Epididymo-orchitis, urethral stricture
  • Disseminated gonococcal infection (septic arthritis, dermatitis, rarely endocarditis/meningitis)
  • Reactive arthritis (chlamydia)
  • Vertical transmission: neonatal conjunctivitis, chlamydial pneumonia
  • Enhanced HIV transmission

Exam pearls

  • CDC/BASHH 2021 moved chlamydia first-line back to doxycycline (superior, esp. rectal) over single-dose azithromycin
  • Always take a gonococcal CULTURE before treatment - ceftriaxone-resistant and XDR gonorrhoea are emerging; test-of-cure is mandatory
  • Treat empirically and treat partners - don't wait for confirmation if clinical suspicion is high
  • Low threshold to treat PID empirically; delay harms fertility
  • Opportunistic full STI screen (HIV, syphilis) and health-adviser partner notification are part of the ED job

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.